2438 Miyanoura Machi, Kagoshima City, Kagoshima, Japan
Summary
The estimated value of insider holdings of Shin Nippon Biomedical Laboratories, Ltd. is at least $10M dollars as of June 8, 2023. Shin Nippon Biomedical Laboratories, Ltd. is the 10%+ Owner of Satsuma Pharmaceuticals, Inc. and owns shares of Satsuma Pharmaceuticals, Inc. stock worth about $10M.
Insider Transactions Reported by Shin Nippon Biomedical Laboratories, Ltd.:
Sym
Company
Class
Transaction
%
Value $
* Price $
Shares
Shares After
Date
Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.